Advertisement
Screener

Siga Technologies INC (SIGA) Share-based Payment Arrangement, Expense

2.8 / 5 stars · 68/120 Roast Me

Siga Technologies INC Share-based Payment Arrangement, Expense

Siga Technologies INC (SIGA) reported Share-based Payment Arrangement, Expense of $3.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-10

  • Siga Technologies INC share-based payment arrangement, expense for the quarter ending 2012-12-31 was $400.00K, a 76.47% decline year-over-year.
  • Siga Technologies INC share-based payment arrangement, expense for the quarter ending 2012-09-30 was $400.00K, a 84.00% decline year-over-year.
  • Siga Technologies INC share-based payment arrangement, expense for the quarter ending 2011-12-31 was $1.70M.
  • Siga Technologies INC share-based payment arrangement, expense for the quarter ending 2011-09-30 was $2.50M.
  • Siga Technologies INC share-based payment arrangement, expense for fiscal 2025 was $3.70M, a 2.78% increase from fiscal 2024.
  • Siga Technologies INC share-based payment arrangement, expense for fiscal 2024 was $3.60M, a 71.43% increase from fiscal 2023.
  • Siga Technologies INC share-based payment arrangement, expense for fiscal 2023 was $2.10M, a 16.67% increase from fiscal 2022.
  • Siga Technologies INC share-based payment arrangement, expense for fiscal 2022 was $1.80M, a 38.46% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 monthShare-based Payment Arrangement, Expense 12 month as first filed
2025-12-31$3.70M
10-K · filed 2026-03-10
2024-12-31$3.60M
10-K · filed 2026-03-10
2023-12-31$2.10M
10-K · filed 2026-03-10
2022-12-31$1.80M
10-K · filed 2025-03-11
2021-12-31$1.30M
10-K · filed 2024-03-12
2020-12-31$1.40M
10-K · filed 2023-03-02
2019-12-31$2.10M
10-K · filed 2022-03-03
2018-12-31$2.30M
10-K · filed 2021-03-04
2017-12-31$1.10M
10-K · filed 2020-03-05
2016-12-31$800.00K
10-K · filed 2019-03-06
$775.54K
10-K · filed 2017-03-07
2015-12-31$1.60M
10-K · filed 2018-03-06
2014-12-31$2.40M
10-K · filed 2017-03-07
2013-12-31$2.30M
10-K · filed 2016-03-04
2012-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06
$800.00K
derived: sum of 2 quarters · filed 2015-03-06
$1.80M
10-K · filed 2015-03-06
2012-09-30$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$1.40M
10-Q · filed 2012-11-05
2012-06-30$1.00M
10-Q · filed 2012-08-06
2011-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$4.20M
derived: sum of 2 quarters · filed 2014-03-10
$12.50M
10-K · filed 2014-03-10
2011-09-30$2.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$10.80M
10-Q · filed 2012-11-05
2011-06-30$8.30M
10-Q · filed 2012-08-06
2010-12-31$1.50M
10-K/A · filed 2013-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B